|
|||||
|
|
Takayasu arteritis developing during treatment of ulcerative colitis with infliximab |
|
| Authors: | Yoshiro Horai Oka Satoru Samuel Lapalme-Remis Remi Sumiyoshi Yoshikazu Nakashima Takahisa Suzuki Akitomo Okada Shin-ya Kawashiri Kunihiro Ichinose Mami Tamai Satoshi Yamasaki Hideki Nakamura Fuminao Takeshima Tomoki Origuchi Atsushi Kawakami |
| Affiliation: | 1. Unit of Translational Medicine, Department of Immunology and Rheumatology, Nagasaki University, Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan 2. Division of Neurology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada 3. Unit of Translational Medicine, Department of Gastroenterology and Hepatology, Nagasaki University, Graduate School of Biomedical Sciences, Nagasaki, Japan 4. Unit of Translational Medicine, Department of Rehabilitation Sciences, Nagasaki University, Graduate School of Biomedical Sciences Biomedical Sciences, Nagasaki, 852-8523, Japan |
| Abstract: | A 22-year-old female with ulcerative colitis that was successfully treated with infliximab (IFX), and remained stable following tapered discontinuation of prednisolone, developed anterior neck pain and elevation of C-reactive protein following her fourth administration of IFX. She was diagnosed with Takayasu arteritis (TA) based on neck ultrasound and computed tomography angiography. This is the first report describing the development of TA during treatment of UC with IFX. |
| Keywords: | Takayasu arteritis Ulcerative colitis Infliximab |
| 本文献已被 SpringerLink 等数据库收录！ | |